Increased Bleeding Risk in a Patient with Oral Anticoagulant Therapy and Concomitant Herbal Intake - A Case Report.
ginger
hemoptysis
herbal intake
rivaroxaban
Journal
EJIFCC
ISSN: 1650-3414
Titre abrégé: EJIFCC
Pays: Italy
ID NLM: 101092742
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
entrez:
19
3
2019
pubmed:
19
3
2019
medline:
19
3
2019
Statut:
epublish
Résumé
We report the case of a 36-year old male, under stable rivaroxaban therapy for 18 months, who was admitted to our emergency room with sudden onset of hemoptysis. Anticoagulant therapy was given after recurrent spontaneous deep vein thrombosis (DVT) and a heterozygous Factor-V-Leiden mutation was present. There was no co-medication reported, however, the patient reported a constant intake of three liters of home-brewn ginger tea per day in the last month. The patient was hospitalized to further investigate the reason of hemoptysis.
Types de publication
Case Reports
Langues
eng
Pagination
95-98Références
N Engl J Med. 2010 Dec 23;363(26):2499-510
pubmed: 21128814
N Engl J Med. 2013 Oct 10;369(15):1406-15
pubmed: 23991658
PLoS One. 2015 Apr 23;10(4):e0122520
pubmed: 25905638
ScientificWorldJournal. 2015;2015:816364
pubmed: 26106644
Blood Rev. 2017 Jul;31(4):193-203
pubmed: 28196633
N Engl J Med. 2017 Mar 30;376(13):1211-1222
pubmed: 28316279
Food Chem Toxicol. 2017 Jul;105:186-193
pubmed: 28414123
BMC Geriatr. 2017 Oct 16;17(Suppl 1):223
pubmed: 29047348
Br J Clin Pharmacol. 2018 Mar;84(3):590-601
pubmed: 29148592
Drugs Aging. 2017 Dec;34(12):891-905
pubmed: 29196903